Abstract
Antigenic analysis of Inoue-Melnick virus, formerly called SMON virus, showed that isolates from patients with subacute myelo-optico-neuropathy (SMON) in Japan, thus far tested, belonged to a single antigenic type (type 1). However, Inoue-Melnick virus isolates obtained so far in the United States chiefly from patients with multiple sclerosis could be classified into three types: type 1, type 2, and an intermediate type. At the present state of knowledge, the virus has not been proven to be the causative agent of disease, hence its provisional designation as IMV.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Inoue Y. K., Nishibe Y., Nakamura Y. Virus associated with S.M.O.N. in Japan. Lancet. 1971 Apr 24;1(7704):853–854. doi: 10.1016/s0140-6736(71)91513-3. [DOI] [PubMed] [Google Scholar]
- Melnick J. L., Seidel E., Inoue Y. K., Nishibe Y. Isolation of virus from the spinal fluid of three patients with multiple sclerosis and one with amyotrophic lateral sclerosis. Lancet. 1982 Apr 10;1(8276):830–833. doi: 10.1016/s0140-6736(82)91876-1. [DOI] [PubMed] [Google Scholar]
- Nishibe Y., Kimura T., Inoue Y. K. Properties of virus associated with subacute myelo-optico-neuropathy. Arch Gesamte Virusforsch. 1973;40(3):189–197. doi: 10.1007/BF01242537. [DOI] [PubMed] [Google Scholar]